PHAXIAM Therapeutics announces the completion of its reverse share split
PHAXIAM Therapeutics announces the completion of its reverse share split
Lyon (France) and Cambridge (MA, US), September 18th,2023 - PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM) (the "Company"), announces the completion today of the reverse share split of the shares composing the Company's share capital, as decided by the Executive Director on July 27th, 2023, following sub-delegation granted by the Board of Directors on June 23rd, 2023, made in accordance with the twenty-third extraordinary resolution of the General Shareholders' Meeting of June 23rd, 2023.
The reverse share split involved the exchange of ten (10) existing shares with a par value of ten euro cents (€0.10) (the "Existing Shares") for one (1) new share with a par value of one euro (€1) (a "New Share").
The main features of this reverse share split, as detailed in the notice of reverse share split published in the Bulletin des AnnoncesLégalesObligatoires (BALO) on July 31st, 2023 and in the press release published by the Company on July 27th, 2023, are as follows:
- Number of Existing Shares subject to the reverse share split: sixty million seven hundred and fifty-one thousand and fifty-four (60,751,054) shares, each with a par value of ten euro cents (€0.10).
- Number of New Shares resulting from the reverse share split: six million seventy-five thousand one hundred and five (6,075,105) shares with a par value of one euro (€1) each.
- Listing of the New Shares: the New Shares resulting from the reverse share split have been admitted to trading on the Euronext regulated market in Paris, with effect from today, the first day of trading, and have been assigned a new ISIN code (FR001400K4B1).
Shareholders who were unable to obtain a number of shares that is a multiple of ten (10) will be compensated by their financial intermediary in accordance with Articles L. 228-6-1 and R. 228-12 of the French Commercial Code and market practice.
The next steps of the reverse share split will take place according to the following indicative timetable:
|September 18th, 2023||Listing of the New Shares|
|September 19th2023||Book-entry of the New Shares (Record date)|
|September 20th, 2023||Date of payment-delivery of the New Shares|
Adjustment of the exercise parity of rights or securities giving access to the capital: a subsequent notice will be published in the Bulletin des AnnoncesLégales et Obligatoires (BALO) to specify the terms of adjustment of the rights of holders of rights or securities giving access to the capital. In connection with the reverse share split described above, The Bank of New York Mellon (“BNY Mellon”), depositary for the Company’s American Depositary Receipt (“ADR”) program, will effect a reverse stock split on such ADR program with an effective date of September 18, 2023. Effective September 18, 2023, ADR holders of the Company will be required on a mandatory basis to surrender their old ADR(s) to BNY Mellon for cancellation and exchange to receive one (1) new American Depositary Share (“ADS”) (CUSIP: 29604W207) for every ten (10) old ADSs (CUSIP: 29604W108). Holders of ADSs in the Direct Registration System or in brokerage accounts will have their ADRs automatically exchanged and need not take any action. No fraction of an ADS will be issued. BNY Mellon will attempt to sell any fractions and distribute the cash proceeds to ADR holders.
PHAXIAMisabiopharmaceuticalcompanydevelopinginnovativetreatmentsforresistantbacterialinfections,which are responsible for many serious infections. The company is building on an innovative approach based on theuse ofphages,naturalbacterial-killingviruses.PHAXIAMisdevelopingaportfolioofphagestargeting3ofthemost resistantanddangerousbacteria,whichtogetheraccountformorethantwo-thirdsofresistanthospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonasaeruginosa.
& Bio, CAC Mid & Small, CAC All Tradable, EnterNext PEA-PME 150 and Next Biotechindexes. For more information, please visitwww.erytech.com
COO & CFO
+33 4 78 74 44 38
Mathilde Bohin / Dusan Oresansky
Investors Relations ArthurRouillé
+33 1 44 71 94 94
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Northland Power Announces Appointment of Ellen Smith to Its Board of Directors30.11.2023 00:09:14 CET | Press release
TORONTO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) announces the expansion of its Board of Directors from nine to ten members and the appointment of Ellen Smith as a Director, effective November 29, 2023. Ms. Smith brings over 35 years of leadership experience within the power and utilities sector. After spending her early career at original equipment manufacturers GE Power Systems and Pratt & Whitney, Ms. Smith led a co-gen business initiative and power & utilities facilities at a refinery of Hess Corp., and led U.S. Operations at National Grid, which included gas and electric transmission and distribution, LNG operations and power generation. For the last decade, Ms. Smith has been the Senior Managing Director at FTI Consulting, where she advises clients on strategy operational issues, and corporate finance, with a focus on power and utilities and EPC clients. Ms. Smith serves as an expert in complex power and utilities litigatio
Constellation Brands to Present at the 2023 Morgan Stanley Global Consumer and Retail Conference on December 5, 202329.11.2023 22:30:33 CET | Press release
VICTOR, N.Y., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today that Garth Hankinson, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 2023 Morgan Stanley Global Consumer and Retail Conference on Tuesday, December 5, 2023 in New York, NY. The presentation is scheduled to begin at 1:30 p.m. ET and is expected to cover the company’s strategic business initiatives, financial metrics, and operating performance, as well as outlook for the future. A live, listen-only webcast of the presentation will be available on the company’s investor relations website at ir.cbrands.com under the News & Events section. When the presentation begins, financial information discussed in the presentation, and a reconciliation of reported GAAP financial measures with comparable and other non-GAAP financial measures, will also be available on the company’s investor relations website under t
CNH Industrial: Periodic Report on $1 Billion Buyback Program29.11.2023 22:30:00 CET | Press release
Basildon, November 29, 2023 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announces that under the €400 million component (the “First Component”) of its $1 billion share buyback program the Company completed transactions in the period November 20, 2023 through November 24, 2023, reported in aggregate, as set forth in the table below. After the purchases announced today and considering those previously executed under the First Component, the total invested amount in the First Component is approximately €163,979,188.20 ($177,525,418.19) or a total amount of 17,560,075 common shares purchased. DateNumber of common shares purchasedAverage price per share excluding feesConsideration excluding fees Consideration (*) excluding fees(€)(€)($) November 20, 2023 473,000 9.5539 4,518,994.70 4,938,357.41 November 21, 2023 2,190,000 9.2275 20,208,225.00 22,138,110.49 November 22, 2023 1,494,075 9.1293 13,639,858.90 14,882,450.04 November 23, 2023 1,000,000 9.1982 9,198,200.00 10,026,038.00 November 24
nCino Reports Third Quarter Fiscal Year 2024 Financial Results29.11.2023 22:05:00 CET | Press release
Total Revenues of $121.9M, up 16% year-over-year Subscription Revenues of $104.8M, up 19% year-over-yearGAAP Operating Margin of (11)%, up 700 basis points year-over-yearNon-GAAP Operating Margin of 17%, up 1,400 basis points year-over-year WILMINGTON, N.C., Nov. 29, 2023 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking for the global financial services industry, today announced financial results for the third quarter of fiscal year 2024, ended October 31, 2023. “We posted another solid quarter in Q3, with revenues and profitability again exceeding expectations,” said Pierre Naudé, Chairman and CEO of nCino. “Notably, we added key new customers, such as our first enterprise Consumer ending deal with a $200 billion bank in the U.S., and our largest customer to date in Japan. We are also pleased that our U.S. mortgage business achieved double-digit revenue growth despite generationally-high interest rates." Naudé continued, "With years of experience successfully
Torqx declares offer for Beter Bed Holding unconditional; 95.14% of Shares now tendered or committed29.11.2023 20:15:00 CET | Press release
JOINT PRESS RELEASE This is a joint press release by Beter Bed Holding N.V. ("Beter Bed Holding" or the "Company") and 959 B.V. (the "Offeror"), a company controlled by Torqx Capital Partners ("Torqx"). This joint press release is issued pursuant to the Article 16, paragraphs 1 and 2, Article 17 paragraph 1 and Article 4, paragraph 3 of the Netherlands Decree in Public Takeover Bids (Besluit openbare biedingen Wft, the "Decree") in connection with the recommended public offer by the Offeror for all the issued and outstanding shares in the capital of the Company (the "Offer"). This press release does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities in the Company. Any offer is only made by means of the offer memorandum (the "Offer Memorandum"), dated 4 October 2023, approved by the Dutch Authority for the Financial Markets (Autoriteit Financiële Markten, the "AFM"). Terms not defined in this press release will have the meaning as set fort